Conmed (CNMD) Tops Q2 EPS by 88c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
CONMED Corporation Announces Second Quarter 2020 Financial Results
July 29, 2020 4:05 PM EDTUTICA, N.Y.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2020.
Second Quarter 2020 Highlights
Sales of $157.8 million decreased 33.8% year over year as reported and 32.6% in constant currency. Domestic revenue decreased 32.2% year over year. International revenue decreased 35.6% as reported and 33.0% in constant currency. Diluted net loss per share (GAAP) was $0.96, compared to diluted net earnings per share of $0.19 in the second quarter of 2019. Adjusted diluted net loss per share(1) was $0.07 versus... More